During a live surgical webcast originating at Springhill Medical Center, gynecologic surgeons from all over the world will have the unique opportunity to view a hysteroscopic myomectomy, featuring the ...

Hologic, Inc. HOLX recently launched an expanded Omni suite, a comprehensive gynecological surgical offering. The expanded Omni suite aims to optimize diagnostic and operative hysteroscopy in Europe, ...

SAN JOSE, Calif., Nov. 8, 2019 /PRNewswire/ -- Meditrina, Inc. will launch the Aveta™ Hysteroscopy System at the 2019 American Association of Gynecologic Laparoscopists meeting. The Aveta™ ...

Hologic, Inc. HOLX recently announced the launch of new Fluent fluid management system in the United States. Per the company, this system is embedded with features that simplify and improvise the ...

Interlace Medical Inc. of Framingham has received clearance from the U.S. Food and Drug Administration to market a system for the removal of uterine polyps. According to Interlace, its MyoSure ...

MARLBOROUGH, Massachusetts, Jan. 3, 2018 /PRNewswire/ -- Hologic, Inc. (Nasdaq: HOLX) announced today that the MyoSure ® MANUAL device, which was designed to simplify tissue removal procedures ...

A hysteroscopy is a procedure doctors use to diagnose and treat conditions involving the uterus and cervix, such as abnormal uterine bleeding, abnormal endometrial thickening, bleeding after menopause ...

Hologic's ($HOLX) two-year patent battle with Smith & Nephew ($SNN) over the patent to a surgical device has come to an end, and Hologic will have to fork over $4 ...

Hologic’s HOLX GYN Surgical segment posted fourth-quarter revenues of $172.5 million, up 10.2% year over year. This marked the strongest growth in fiscal 2025, as the company had earlier anticipated, ...